HCW Biologics Inc. (HCWB)
1.17
+0.05
(+4.46%)
USD |
NASDAQ |
Oct 23, 16:00
1.14
-0.03
(-2.56%)
After-Hours: 20:00
HCW Biologics Market Cap : 1.893M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.893M |
| October 22, 2026 | 1.812M |
| October 21, 2026 | 1.876M |
| October 20, 2026 | 1.893M |
| October 19, 2026 | 1.990M |
| October 16, 2026 | 2.006M |
| October 15, 2026 | 1.990M |
| October 14, 2026 | 1.893M |
| October 13, 2026 | 2.038M |
| October 12, 2026 | 2.394M |
| October 09, 2026 | 2.588M |
| October 08, 2026 | 2.475M |
| October 07, 2026 | 2.524M |
| October 06, 2026 | 2.540M |
| October 05, 2026 | 2.653M |
| October 02, 2026 | 2.718M |
| October 01, 2026 | 2.734M |
| September 30, 2026 | 2.766M |
| September 29, 2026 | 2.831M |
| September 28, 2026 | 2.944M |
| September 25, 2026 | 3.122M |
| September 24, 2026 | 3.219M |
| September 23, 2026 | 2.685M |
| September 22, 2026 | 2.928M |
| September 21, 2026 | 3.090M |
| Date | Value |
|---|---|
| September 18, 2026 | 3.025M |
| September 17, 2026 | 3.154M |
| September 16, 2026 | 3.251M |
| September 15, 2026 | 3.316M |
| September 14, 2026 | 3.559M |
| September 11, 2026 | 3.623M |
| September 10, 2026 | 3.931M |
| September 09, 2026 | 3.979M |
| September 08, 2026 | 4.060M |
| September 04, 2026 | 4.756M |
| September 03, 2026 | 4.642M |
| September 02, 2026 | 5.427M |
| September 01, 2026 | 5.581M |
| August 31, 2026 | 5.807M |
| August 28, 2026 | 5.548M |
| August 27, 2026 | 5.128M |
| August 26, 2026 | 4.368M |
| August 25, 2026 | 4.206M |
| August 24, 2026 | 3.737M |
| August 21, 2026 | 3.526M |
| August 20, 2026 | 3.429M |
| August 19, 2026 | 3.720M |
| August 18, 2026 | 3.446M |
| August 17, 2026 | 4.076M |
| August 14, 2026 | 4.335M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.189B |
| Oncolytics Biotech, Inc. | 62.61M |
| Sangamo Therapeutics, Inc. | 47.64M |
| Sarepta Therapeutics, Inc. | 1.873B |
| Anixa Biosciences, Inc. | 103.41M |
Market Cap Related Metrics
| PS Ratio | 0.1381 |
| Price to Book Value | 0.2548 |
| Price | 1.17 |
| Earnings Yield | -2.43K% |